ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1872

Nationwide Analysis of Prosthetic Joint Complications with and Without Inflammatory Arthritis

Annika Sengupta1, Faria Sami2 and Shilpa Arora3, 1John H Stroger Hospital of Cook County, Chicago, IL, 2University of Alabama, Chicago, IL, 3Cook County Hospital, Chicago, IL

Meeting: ACR Convergence 2024

Keywords: Epidemiology, Prosthetic Joint

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Monday, November 18, 2024

Title: Epidemiology & Public Health Poster III

Session Type: Poster Session C

Session Time: 10:30AM-12:30PM

Background/Purpose: Prosthetic joint complications (PJC) are a major concern after joint replacement surgeries especially in patients with history of inflammatory arthritis. We aimed to compare PJC hospitalizations among patients with and without inflammatory arthritis (IA).

Methods: We utilized the 2016-2020 National Inpatient Sample (NIS) Database to obtain all PJC hospitalizations. These were divided into two groups of with and without IA (Rheumatoid Arthritis, Spondylarthritis, Psoriatic Arthritis or Inflammatory Bowel Disease related arthritis). The two groups were compared for demographics, length of stay, total charges and outcomes using Chi square and Wilcoxon rank-sum tests. We also compared individual PJC in all adult hospitalizations with and without IA.

Results: We identified a total of 869,519 PJC hospitalizations out of which 54,705 (6.3%) had a concomitant diagnosis of IA. There were several epidemiological differences between the two groups of PJC hospitalizations those with and without IA (Table 1). Those with IA were younger (median, IQR age 68, 61-75 vs 69, 61-78, P value < 0.001), had higher proportion of females (75% vs 57%, P value < 0.001), had a marginally higher proportion of minorities (African-Americans, 9% vs 8%, P value 0.015 , Hispanics, 6% vs 5%, P value < 0.001 and Native Americans, 0.8% vs 0.5%, P value < 0.001) and were more likely to have Medicare insurance (72% vs 68%, P value < 0.001) and less likely to be privately insured (20% vs 21%, P value < 0.001) in comparison to those without IA. Sepsis was more common in the IA group (7% vs 6%, P value < 0.001) with longer length of stay (median, IQR 4, 2-7 vs 4, 2-6, P value < 0.001) and higher total hospital charges (Table 1). Overall unadjusted mortality was lower in the IA group (0.7% vs 1%, P value 0.11) in comparison to the non-IA group. All individual PJC (periprosthetic fracture, infection, osteolysis, broken internal joint prosthesis, dislocation, mechanical loosening, and wear of articular surface) were higher in those with IA than those without concomitant IA (P value < 0.001) (Table 2).

Conclusion: Out of all PJC hospitalizations, 1 in 16 had a concomitant diagnosis of chronic inflammatory arthritis. Those with IA were younger, more often female, and exhibit higher comorbidity burden, which translated to slightly longer hospital stay and higher total charges. IA patients were more susceptible to sepsis as well as all individual prosthetic joint complications in comparison to those without IA.

Supporting image 1

Supporting image 2


Disclosures: A. Sengupta: None; F. Sami: None; S. Arora: None.

To cite this abstract in AMA style:

Sengupta A, Sami F, Arora S. Nationwide Analysis of Prosthetic Joint Complications with and Without Inflammatory Arthritis [abstract]. Arthritis Rheumatol. 2024; 76 (suppl 9). https://acrabstracts.org/abstract/nationwide-analysis-of-prosthetic-joint-complications-with-and-without-inflammatory-arthritis/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2024

ACR Meeting Abstracts - https://acrabstracts.org/abstract/nationwide-analysis-of-prosthetic-joint-complications-with-and-without-inflammatory-arthritis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology